Clinical features in a series of 258 Japanese pediatric patients with thrombotic microangiopathy

[1]  S. Iyoda,et al.  Secondary Shiga Toxin–Producing Escherichia coli Infection, Japan, 2010–2012 , 2016, Emerging infectious diseases.

[2]  M. Nangaku,et al.  Clinical guides for atypical hemolytic uremic syndrome in Japan , 2016, Clinical and Experimental Nephrology.

[3]  G. Ardissino,et al.  Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network , 2016, European Journal of Pediatrics.

[4]  J. Craig,et al.  The long-term outcomes of atypical haemolytic uraemic syndrome: a national surveillance study , 2016, Archives of Disease in Childhood.

[5]  L. Rostaing,et al.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[6]  Lawrence Copelovitch,et al.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome , 2013, Pediatric Nephrology.

[7]  K. Ong,et al.  Strategies for Surveillance of Pediatric Hemolytic Uremic Syndrome: Foodborne Diseases Active Surveillance Network (FoodNet), 2000–2007 , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  H. Karch,et al.  Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  G. Remuzzi,et al.  Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[10]  Amy E. Weaver,et al.  Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome , 2010, Human mutation.

[11]  L. Zimmerhackl,et al.  Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS) , 2008, Pediatric Nephrology.

[12]  H. Karch,et al.  Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. , 2002, The Journal of infectious diseases.

[13]  C. Beresford,et al.  Haemolytic Uraemic Syndrome , 1984, The Lancet.

[14]  [Clinical Guides for Atypical Hemolytic Uremic Syndrome in Japan]. , 2016, Nihon Jinzo Gakkai shi.